Merck Bovilis® Nasalgen® IP
Merck
Item Details
BOVILIS® NASALGEN® IP
Bovine Rhinotracheitis-Parainfluenza 3 Vaccine
Product Description
The original intranasal.
Designed for convenience, the original BOVILIS® NASALGEN® IP vaccination is an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and parainfluenza 3 (PI3) viruses.
Indications
This product has been shown effective for the vaccination of healthy cattle 5 months of age or older against infectious bovine rhinotracheitis and parainfluenza 3 viruses. Duration of immunity has not been established.
Diseases
- Infectious bovine rhinotracheitis (IBR)
- Parainfluenze 3 (PI3)
Designed for no injection site reactions to help your operation meet Beef Quality Assurance standards.
Key Benefits
Fast-acting to build a strong foundation
- Provides rapid onset of protection
- No temperature sensitivity issues that would negatively impact replication once administered2
- Stimulates active immunity in the face of maternal antibodies1
Innovative Intranasal Delivery
- Stimulates local production of antibodies at the site where infectious pathogens enter the respiratory system – the mucosal lining of the nasal cavity
